Dxcover PANAROMIC Platform

COMPANY FORMATION

$2M SEED INVESTMENT

To spinout from the University of Strathclyde

METHOD PATENT GRANTED

Patent granted in EU, US and China for all cancers

$5M SEED INVESTMENT

Triggering ownership of all Intellectual Property.

BRAIN-ED1 PUBLICATION

385 prospective patient study confirms ability to detect brain cancer in Brain Communications.

CANCER PUBLICATION

Confirms early detection of small and low grade brain tumors

PLATFORM PATENT GRANTED

Patent granted in the US for PANAROMIC™ Platform

BRAIN ED2 PUBLICATION

Prospective study on 988 patients published in neuro-oncology advances.

ISO 13485

Quality Management System Certification

$11.5M SERIES A

$9M equity, $2.5M EU Grant to progress brain cancer and colorectal cancer product development

CREATE-1 STUDY

CRC & AA DATA presented at AACR

EMBRACE STUDY

2,200 patient performance evaluation for Dxcover Brain Cancer started across 7 European clinical sites

MULTI CANCER PUBLICATION

On 2,092 patients confirms ability to detect early-stage tumors across 8 cancers

1ST PRIZE AT ESMO

For poster multi-cancer data

GLOBAL LIFE SCIENCE PARTNER

Signed Partnership with global Life Science Partner

CREATE-2 STUDY

Prospective recruitment of 1,000 patients in the US for colorectal cancer early detection

DXCOVER INC.

Dxcover incorporated in the US.

EMBRACE STUDY

Patient recruitment complete